• Теги
    • избранные теги
    • Компании595
      • Показать ещё
      • Показать ещё
      Страны / Регионы109
      • Показать ещё
      Международные организации18
      • Показать ещё
      • Показать ещё
St Jude Medical
20 апреля, 19:16

Keep it 100

There just might be $100 billion of cash looking for a deal. JPMorgan’s global mergers chairman, Kurt Simon, recently dangled the audacious notion that the capital markets could fully finance

19 апреля, 17:44

Abbott (ABT) Tops Q1 Earnings on Strong EPD, Medical Device

Abbott Laboratories (ABT) reported first-quarter 2017 adjusted earnings from continuing operations of 48 cents per share, up 17.1% year over year.

Выбор редакции
15 апреля, 20:00


THAT’S UPSETTING, SINCE THIS IS THE ONE THE INSTA-WIFE HAS: St. Jude Medical Played Down Defibrillator Failures for Years, F.D.A. Says.

31 марта, 16:44

Abbott's St Jude Buyout to Boost Business, Risks Remain

On Mar 31, we updated our research report on medical device major, Abbott Laboratories (ABT).

23 марта, 00:56

MedTech Long-Term Prospects Impress: Which Stocks to Buy?

MedTech Long-Term Prospects Impress: Which Stocks to Buy?

20 марта, 16:14

Abbott Laboratories' MitraClip Outcome Positive for DMR

Abbott Laboratories (ABT) recently presented one-year positive outcomes from the study of the MitraClip system in transcatheter mitral valve repair (TMVR) procedures in the U.S.

26 января, 02:08

Abbott Laboratories Gains Despite Unimpressive Q4 Revenue Results

Abbott Laboratories (ABT) just released its fourth quarter fiscal 2016 earnings results, posting earnings of $0.65 per share and revenue of $5.33 billion.

25 января, 19:00

Abbott Labs (ABT) Tops Q4 Earnings Estimates, Sales In Line

Abbott Laboratories (ABT) reported fourth-quarter 2016 earnings from continuing operations of 65 cents per share, a penny higher than the Zacks Consensus Estimate.

25 января, 17:37

Abbott Laboratories (ABT): Tops Q4 Earnings, Sales in Line

Abbott Laboratories (ABT) earnings per share has beaten the Zacks Consensus Estimated while its revenues were almost in line with the mar.

21 января, 01:53

What's in Store for Abbott Labs (ABT) This Earnings Season?

Abbott Laboratories (ABT) is scheduled to report fourth-quarter and full year 2016 results before the opening bell on Jan 25.

Выбор редакции
12 января, 05:13

21ST CENTURY HEADLINES: St. Jude Medical releases security patches for vulnerable cardiac devices. …

21ST CENTURY HEADLINES: St. Jude Medical releases security patches for vulnerable cardiac devices. “The transmitters record and receive RF traffic from the embedded medical devices before sending this information to physicians through the Merlin.net Patient Care Network. The US agency has investigated a set of security flaws found within this setup by MedSec and has […]

Выбор редакции
11 января, 23:10

Кардиостимуляторы St. Jude Medical оказались уязвимы для атак, компания выпустила патч

Компания St. Jude Medical все же была вынуждена признать уязвимость своих продуктов после прошлогоднего скандала.

Выбор редакции
Выбор редакции
04 января, 15:06

IDEXX Laboratories (IDXX) Set to Join the S&P 500 Index

IDEXX Laboratories, Inc. (IDXX) is scheduled to join the coveted S&P 500 benchmark, after the market closes on Jan 4.

02 января, 15:40

Abbott Labs to Close St. Jude Acquisition Later this Week

Abbott Laboratories (ABT) announced to close the acquisition of St. Jude Medical, Inc., (STJ) on Jan 4, 2017.

30 декабря 2016, 01:38

Abbott to Sell 2 Medical Device Businesses for St. Jude Buyout

Abbott Laboratories (ABT) has agreed to divest two medical device businesses in order to settle Federal Trade Commission (FTC) charges in relation to its proposed acquisition of St. Jude Medical (STJ).

Выбор редакции
29 декабря 2016, 16:30

Abbott's St. Jude Deal Aligns With Shift To Value-Based Care

The Federal Trade Commission’s approval of Abbott Laboratories’ $25 billion purchase of St. Jude Medical helps the larger company cope with value-based care and bundled payments to doctors and hospitals.

Выбор редакции
28 декабря 2016, 08:30

Антимонопольные органы США одобрили сделку между Abbott и St. Jude Medical

Вчера, 27 декабря, антимонопольные органы США одобрили $25-миллиардную сделку по приобретению американской фармацевтической компанией Abbott Laboratories производителя медицинских устройств St. Jude Medical. Напомним, что месяцем ранее сделка была одобрена Европейской комиссией при условии, что Abbott выведет два актива в сфере лечения сердечно-сосудистой системы.